| [1] |
Mun EC, Blackburn GL, Matthews JB, et al. Current Status of medical and surgical therapy for obesity [J]. Gastroenterology, 2011,120(3):669-681.
|
| [2] |
Amos AF, McCarty DJ, Zimmer P. The rising global burden of diabetes and its complications; estimates and projections to the year 2010 [J]. Diabet Med, 1997, 14 suppl 5: S1-85.
|
| [3] |
中华医学会糖尿病学分会,中华医学会外科学分会.手术治疗糖尿病专家共识[J].中华糖尿病杂志, 2011. 3(3):205-208.
|
| [4] |
Grice EA, Segre JA. The human microbiome: our second genome[J].Annu Rev Genomics Hum Gene, 2012, 13:151-170.
|
| [5] |
Tiihonen K, Ouwehand AC, Rautonen N. Human intestinal microbiota and healthy ageing [J].Aging Res Rev, 2010, 9(2):107-116.
|
| [6] |
Miller TL, Wolin MJ. Stability of Methanobrevibacter smithii populations in the microbial flora excreted from the human large bowel[J]. Appl Environ Microbiol, 1983, 45(1):317-318.
|
| [7] |
Sekirov I, Russell SL, Antunes LC, et al. Gut microbiota in health and disease[J]. Physiol Rev, 2010, 90(3) :859-904.
|
| [8] |
Amano A. Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease[J]. J Periodontal, 2003, 74(1): 90-96.
|
| [9] |
Watanabe K, Petro BJ, Shlimon AE, et al. Effect of periodontitis on insulin resistance and the onset of type 2 diabetes mellitus in Zucker diabetic fatty rats[J]. J Periodontol, 2008, 79(7): 1208-1216.
|
| [10] |
Iwamoto Y, Nishimura F, Nakagawa M, et al.The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes [J]. J Periodontol, 200, 72(6):774-778.
|
| [11] |
Wen L, Ley RE, Volchkov PY, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes[J]. Nature, 2008,455 (7216): 1109-1113.
|
| [12] |
Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults[J].PLoS One, 2010, 5(2): e9085.
|
| [13] |
Membrez M, Blancher F, Jaquet M, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice[J]. FASEB J, 2008, 22(7): 2416-2426.
|
| [14] |
WellenKE, Hotamisligil GS. Inflammation, stress, and diabetes[J]. J Clin Invest, 2005, 115(5): 1111-1119.
|
| [15] |
Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice[J]. Diabetes, 2008, 57(6): 1470-1481.
|
| [16] |
Ludwig DS, Ebbeling CB, Livingston EH. Surgical vs lifestyle treatment for type 2 diabetes[J]. JAMA, 2012, 308(10): 981-982.
|
| [17] |
Li JV, Reshat R, Wu Q, et al. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents[J].Front Microbiol, 2011, 2: 183.
|
| [18] |
Furet JP, Kong LC, Tap J, et a1. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers[J]. Diabetes, 2010,59(12): 3049-3057.
|
| [19] |
Derrien M, Vaughan EE, Plugge CM, et al. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium[J].Int J Syst Evol Microbiol, 2004, 54 (Pt5): 1469-1476.
|
| [20] |
Karlsson CL, Onnerfält J, Xu J, et al. The microbiota of the gut in preschool children with normal and excessive body weight[J].Obesity, 2012, 20(11): 2257-2261.
|
| [21] |
Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity[J].Proc Natl Acad Sci U S A, 2013, 110(22 ): 9066-9071.
|
| [22] |
Shin NR, Lee JC, Lee HY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice[J]. Gut, 2014, 63(5): 727-735.
|